Hybrid immunity after BNT162b2 Covid-19 vaccine administration in children aged 5 to 11 years. Tsampalieros A, Zemek R, Barrowman N, Langlois MA, et al. Vaccine 2024 May 23:S0264-410X(24)00588-7. doi: 10.1016/j.vaccine.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Tsampalieros A, Zemek R, Barrowman N, Langlois MA, et al. Hybrid immunity after BNT162b2 Covid-19 vaccine administration in children aged 5 to 11 years. Vaccine 2024 May 23:S0264-410X(24)00588-7. doi: 10.1016/j.vaccine.2024.
PMID: 38789373